z-logo
Premium
Minimum quality criteria are needed in the assessment and communication of unexpected drug safety findings of marketed products from randomized controlled trials
Author(s) -
Hermann Robert,
Cnota Peter,
Maus Joachim
Publication year - 2012
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2012.04176.x
Subject(s) - drug , medicine , randomized controlled trial , quality (philosophy) , pharmacology , intensive care medicine , risk analysis (engineering) , surgery , philosophy , epistemology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom